Prosecution Insights
Last updated: April 19, 2026

Shanghai Benemae Pharmaceutical Corporation

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18324935 NOVEL ANTI-LAG3 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME BUTTICE, AUDREY L 1647 Non-Final OA May 26, 2023
17015500 GLP-1 COMPOSITION FOR TREATING OBESITY AND WEIGHT MANAGEMENT SABILA, MERCY HELLEN 1654 Final Rejection Sep 09, 2020
15045068 STABLE AQUEOUS PARENTERAL PHARMACEUTICAL COMPOSITIONS OF INSULINOTROPIC PEPTIDES KOMATSU, LI N 1658 Final Rejection Feb 16, 2016

Managing Shanghai Benemae Pharmaceutical Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month